Find out how to get
Free shipping

Moment 200 mg - analgesic anti-inflammatory 12 coated tablets

4.9
(57)
See all products: Moment
Productor: Angelini
info prodotto Richiedi info sul prodotto
-34.8%
€4.89
Recommended price €7.50
Available in the following sizes
  • 12 coated tablets
    €4.89
  • 10 soft capsules
    €5.51
  • 24 coated tablets
    Not available
  • 36 coated tablets
    €10.37
Extra quantity discount
from 5 Pieces You're saving: 1,00%
from 10 Pieces You're saving: 2,00%
info resi e spedizione

Information on returns and shipments

info pagamenti

Payment methods

Authorized company for online trading of
Medicines authorized by the Ministry of Health
99& satisfied customers
Product Description

Medicine indicated in the treatment of pain and the symptomatic treatment of febrile or flu-like conditions.

Indications

Moment is a medicine based on ibuprofen useful in the treatment of pain of various origins and nature:

  • headache;
  • toothache,
  • neuralgia;
  • bone, joint and muscle pain;
  • menstrual pain.

Dosage and method of use

Moment can be administered to adults and children over 12 years of age. It is possible to take 1-2 tablets 2-3 times a day.
Do not exceed the dose of 6 tablets per day. Do not exceed the recommended dose. Elderly patients, in particular, should adhere to the minimum dosages indicated above. Take the product on a full stomach.

Contraindications

Do not administer Moment:

  • in patients under 12 years of age;
  • in pregnancy or breastfeeding;
  • in case of hypersensitivity to the active substance, to other antirheumatics (acetylsalicylic acid, etc.) or to any of the excipients;
  • in case of active or severe gastroduodenal ulcer or other gastropathies;
  • in patients with a history of gastrointestinal bleeding or perforation related to previous active treatments, or a history of recurrent peptic ulcer/hemorrhage (two or more distinct episodes of proven ulceration or bleeding);
  • in case of severe hepatic or renal insufficiency;
  • in case of severe cardiac insufficiency.

Special warnings

Use caution in patients whose activities require alertness if they notice drowsiness, dizziness, or depression during therapy with ibuprofen. The use of the drug, as with any drug inhibiting the synthesis of prostaglandins and cyclooxygenase, is not recommended in women intending to become pregnant. Administration should be suspended in women who have fertility problems or who are undergoing investigation of fertility. The use of the medicine should be avoided in conjunction with NSAIDs, including selective COX-2 inhibitors.
Undesirable effects can be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. Clinical trials and epidemiological data suggest that the use of ibuprofen, particularly at high doses (2400 mg/day) and for long-term treatment, may increase the risk of side effects. be associated with a modestly increased risk of arterial thrombotic events (e.g. myocardial infarction or stroke).

Pregnancy and breastfeeding

Pregnancy
Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or embryo-fetal development. Results of epidemiological studies suggest an increased risk of miscarriage, cardiac malformation, and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increases from less than 1%, up to approximately 1.5%.
The risk is believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo-fetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period.
During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension), renal dysfunction, which may progress to renal failure with oligo-hydroamniosis.
At the end of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to possible prolongation of bleeding time, and antiplatelet effect, which may occur even at very low doses, inhibition of uterine contractions resulting in delayed or prolonged labor.

Expiry and storage

Check the expiry date indicated on the package. The expiry date indicated on the package refers to the product in its intact packaging, stored correctly. Store below 25°C.
Caution: Do not use the medicine after the expiry date shown on the package.

Composition

Active ingredient: ibuprofen 200 mg.
Excipients: l-arginine, sodium bicarbonate, sodium bitartrate, lactose, sodium saccharin, grapefruit flavoring, crospovidone.

Format

Pack of 12 coated tablets.

Product Code:FRCM046955

Price Trend

This product has been on sale since 25/09/2017

In the last 30 days, the product's lowest price was 4,89 €

5% EXTRA DISCOUNT on FIRST ORDER! Register and discover the WELCOME Coupon!
To enhance your website experience, Farmacosmo.com uses different types of cookies. You can click OK, to allow them, or manage them individually. By clicking on the ''x'' you don't accept any cookies and other tracking methods other than technical ones. To read more see our Cookie Policy. Cookie Policy